Evidence map›Paper›PMID 37045581›Full record

ArticleBMJ open2023

Clinical spectrum of COVID-19 complications in young adults: combined analysis of the American Heart Association COVID-19 Cardiovascular Disease Registry and the Outcomes Registry for Cardiac Conditions in Athletes.

Aakash Bavishi, Stephanie A Kliethermes, Bradley Petek, Nathaniel Moulson, Pranav Mellacheruvu, Timothy W Churchill, Kimberly Harmon, Manesh R Patel, Aaron L Baggish, Jonathan A Drezner and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 3 countries.

Aakash BavishiDivision of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0000-0003-3012-0380
Stephanie A KliethermesDepartment of Orthopedics and Rehabilitation, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Bradley PetekDepartment of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Nathaniel MoulsonDepartment of Cardiology, The University of British Columbia Library Vancouver Campus, Vancouver, British Columbia, Canada.
Pranav MellacheruvuDepartment of Internal Medicine, Washington State University Elson S Floyd College of Medicine, Spokane, Washington, USA.
Timothy W ChurchillDepartment of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Kimberly HarmonDepartment of Family Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-3670-6609
Manesh R PatelDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Aaron L BaggishDepartment of Sports Science, University of Lausanne, Lausanne, Switzerland.
Jonathan A DreznerDepartment of Family Medicine, Washington State University Spokane, Spokane, Washington, USA.
Raja Kannan MutharasanDivision of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA kannanm@northwestern.edu.
Massachusetts General Hospital · USNorthwestern University · USWashington State University Spokane · USDuke University · USUniversity of British Columbia · CAUniversity of Lausanne · CHUniversity of Washington · USUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile young adults 18-24 years old bear a significant proportion of COVID-19 diagnoses, the risk factors for hospitalisation and severe COVID-19 complications in this population are poorly understood.

objectiveThe objective of this study was to identify risk factors for hospitalisation and other COVID-19 complications across the health spectrum of young adults diagnosed with COVID-19 infection. STUDY

designRetrospective cohort study.

participantsYoung adults (aged 18-24) with confirmed COVID-19 infection from the American Heart Association (AHA) COVID-19 Cardiovascular Disease Registry of hospitalised patients and the Outcomes Registry for Cardiac Conditions in Athletes (ORCCA) study of collegiate athletes. The AHA registry included 636 young adults from 152 hospitals. The ORCCA registry consisted of 3653 competitive college athletes from 42 colleges and universities.

interventionNone (exposure to COVID-19). PRIMARY AND SECONDARY OUTCOME MEASURES: Main outcomes included hospitalisation, death, major adverse cardiovascular events (MACE) and other severe clinical events.

resultsIn comparison to the ORCCA registry, patients in the AHA registry were more likely to be female (59% vs 33%); had higher average body mass index (BMI) (32.4 vs 25.6); and had increased prevalence of diabetes (10% vs 0.4%), hypertension (7% vs 0.6%), chronic kidney disease (2% vs 0%) and asthma (14% vs 8%), all with p<0.01. There were eight (2%) deaths in the AHA hospitalised registry compared with zero in the ORCCA cohort. BMI was a statistically significant predictor of death in the hospitalised cohort (OR 1.05, 95% CI 1.00, 1.10). No significant predictors of MACE or other severe clinical events were identified.

conclusionsThe risk of cardiac events in young adults aged 18-24 diagnosed with COVID-19 infection is low. Patients who were hospitalised (AHA registry) were more likely to have pre-existing medical comorbidities and higher BMI than healthy collegiate athletes (ORCCA registry). Once hospitalised, elevated BMI is associated with increased mortality although other drivers of MACE and other severe clinical events remain unclear.

Indexed as

Cardiovascular DiseasesCOVID-19Heart DiseasesAdolescentAdultAmerican Heart AssociationAthletesFemaleHumansMaleRegistriesRetrospective StudiesUnited StatesYoung AdultAdult cardiologyCOVID-19PUBLIC HEALTH

Identifiers

PMID37045581
PMCPMC10105915
OpenAlexW4365141106

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.